The Lancet - один из наиболее известных, старых и самых авторитетных общих журналов по медицине. The Lancet - независимый международный медицинский журнал общего профиля, основанный в 1823 году Томасом Вакли. С момента своего первого еженедельного выпуска (5 октября 1823 г.) журнал стремился сделать науку широко доступной, чтобы медицина могла служить обществу и преобразовывать его, а также положительно влиять на жизнь людей.

Новый выпуск журнала "The Lancet" включает статьи:

EDITORIAL

• 50 years of SSRIs: weighing benefits and harms

COMMENT

• Integrating research into surveillance: enhancing the response to mpox
• Chronic hand eczema treatment: exploring topical JAK inhibition further
• Is negative pressure wound therapy beneficial for post-surgical wounds?
• From crisis to opportunity: a united response to Trump's attacks on climate action
• Protecting global sexual and reproductive health and rights in the face of retrograde US policies and positions
• WORLD REPORT
• US AI regulatory rollback and health
• Trump works towards US tariffs on drug imports

CORRESPONDENCE

• Cholera risk in Goma, DR Congo, after forced clearing of relief camps
• The impact of US tariff hikes on health care
• USA–China tariffs on pharmaceuticals affect global health equity
• Intimate partner violence and ART adherence in Uganda
• Triple crisis among refugee youth resettled in high-income countries
• The Changing Mindsets Initiative
• Safety of intranasally administered etripamil: RAPID trial update
• Positive RPR and TPLA tests cannot confirm congenital syphilis
• Positive RPR and TPLA tests cannot confirm congenital syphilis – Authors' reply
• Isotretinoin-associated cervical osteophytosis
• Isotretinoin-associated cervical osteophytosis – Authors' reply
• Clinical presentation and epidemiological assessment of confirmed human mpox cases in DR Congo: a surveillance-based observational study
• Efficacy and safety of topical delgocitinib cream versus oral alitretinoin capsules in adults with severe chronic hand eczema (DELTA FORCE): a 24-week, randomised, head-to-head, phase 3 trial
• Negative pressure wound therapy versus usual care in patients with surgical wound healing by secondary intention in the UK (SWHSI-2): an open-label, multicentre, parallel-group, randomised controlled trial

HEALTH POLICY

• Protecting Africa's children from extreme risk: a runway of sustainability for PEPFAR programmes

VIEWPOINT

• A proposed framework for monitoring and evaluating progress at the intersection of women, power, and cancer

Медицинские специалисты Кузбасса могут отправить запрос на 📧medlibchz2025@yandex.ru с пометкой «Хочу читать The Lancet» и получать на свою почту еженедельно свежий выпуск журнала.